中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
28期
20-21,22
,共3页
毕良文%张丽珍%时前军%赵滑峰%田继红%赵维勇%唐鹿群
畢良文%張麗珍%時前軍%趙滑峰%田繼紅%趙維勇%唐鹿群
필량문%장려진%시전군%조활봉%전계홍%조유용%당록군
非小细胞肺癌%生存%预后分析
非小細胞肺癌%生存%預後分析
비소세포폐암%생존%예후분석
Non-small cell Lung cancer%Survival%Prognostic analysis
目的:探讨老年非小细胞肺癌患者生存状况及预后相关因素,为临床治疗提供参考依据。方法回顾性分析87例老年非小细胞肺癌患者的临床资料,利用Kaplan-Meier法进行生存率统计,并进行Log-rank时序检验,利用比例风险模型(Cox模型)进行多因素分析,筛选出相关因素。结果87例老年非小细胞肺癌患者1、2、4年生存率分别为52.9%、26.2%、2.8%,中位生存时间为14个月。单因素分析结果显示,患者的KPS评分、TNM分期、靶向治疗、治疗方式对生存期有影响(P<0.05),多因素分析显示KPS评分、治疗方式是预后的独立因素(P<0.05)。结论 KPS≥70分、能够耐受综合治疗的老年患者应当积极治疗,这些患者的生存期较长,是潜在的治疗获益者。
目的:探討老年非小細胞肺癌患者生存狀況及預後相關因素,為臨床治療提供參攷依據。方法迴顧性分析87例老年非小細胞肺癌患者的臨床資料,利用Kaplan-Meier法進行生存率統計,併進行Log-rank時序檢驗,利用比例風險模型(Cox模型)進行多因素分析,篩選齣相關因素。結果87例老年非小細胞肺癌患者1、2、4年生存率分彆為52.9%、26.2%、2.8%,中位生存時間為14箇月。單因素分析結果顯示,患者的KPS評分、TNM分期、靶嚮治療、治療方式對生存期有影響(P<0.05),多因素分析顯示KPS評分、治療方式是預後的獨立因素(P<0.05)。結論 KPS≥70分、能夠耐受綜閤治療的老年患者應噹積極治療,這些患者的生存期較長,是潛在的治療穫益者。
목적:탐토노년비소세포폐암환자생존상황급예후상관인소,위림상치료제공삼고의거。방법회고성분석87례노년비소세포폐암환자적림상자료,이용Kaplan-Meier법진행생존솔통계,병진행Log-rank시서검험,이용비례풍험모형(Cox모형)진행다인소분석,사선출상관인소。결과87례노년비소세포폐암환자1、2、4년생존솔분별위52.9%、26.2%、2.8%,중위생존시간위14개월。단인소분석결과현시,환자적KPS평분、TNM분기、파향치료、치료방식대생존기유영향(P<0.05),다인소분석현시KPS평분、치료방식시예후적독립인소(P<0.05)。결론 KPS≥70분、능구내수종합치료적노년환자응당적겁치료,저사환자적생존기교장,시잠재적치료획익자。
Objective To study the survival situation and prognostic factors of the elderly patients with non-small cell lung cancer (NSCLC), in order to provide references for clinical treatment. Methods The clinical data of 87 elderly NSCLC patients were retrospectively reviewed. Kaplan-Meier method and log-rank test were used for survival rate analysis, and Cox’s proportion risk model was used for multivariate analysis. Relevant factors were selected after analysis. Results Among all the 87 patients, the survival rates of 1-year, 2-year and 4-year were 52.9%, 26.2%and 2.8%, and the median survival time was 14 months. The univariate analysis showed that patients’karnofsky performance status (KPS) score, Tumor Node Metastasis (TNM) stage, target therapy and the therapy mode were related to survival period (P<0.05). The multivariate analysis indicated that patients’KPS score and the therapy mode were closely related to their prognosis (P<0.05). Conclusion The elderly patients with KPS score≥70 and bearing comprehensive treatment have longer survival time and they can benefit from treatments.